These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 25355053)
1. Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines. Wang L; Wu J; Lu J; Ma R; Sun D; Tang J Mol Med Rep; 2015 Feb; 11(2):931-9. PubMed ID: 25355053 [TBL] [Abstract][Full Text] [Related]
2. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Zhou J; Jiang YY; Chen H; Wu YC; Zhang L Cell Prolif; 2020 Feb; 53(2):e12739. PubMed ID: 31820522 [TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway. Teng Z; Xu S; Lei Q Oncol Rep; 2020 Feb; 43(2):503-515. PubMed ID: 31894340 [TBL] [Abstract][Full Text] [Related]
4. LY294002 and metformin cooperatively enhance the inhibition of growth and the induction of apoptosis of ovarian cancer cells. Li C; Liu VW; Chan DW; Yao KM; Ngan HY Int J Gynecol Cancer; 2012 Jan; 22(1):15-22. PubMed ID: 22080879 [TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancer. Chen X; Zhao M; Hao M; Sun X; Wang J; Mao Y; Zu L; Liu J; Shen Y; Wang J; Shen K Mol Cancer Res; 2013 Oct; 11(10):1269-78. PubMed ID: 23814023 [TBL] [Abstract][Full Text] [Related]
6. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555 [TBL] [Abstract][Full Text] [Related]
7. LY‑294002 enhances the chemosensitivity of liver cancer to oxaliplatin by blocking the PI3K/AKT/HIF‑1α pathway. Xu R; Zhang Y; Li A; Ma Y; Cai W; Song L; Xie Y; Zhou S; Cao W; Tang X Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982772 [TBL] [Abstract][Full Text] [Related]
8. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of Prostate Cancer DU-145 Cells Proliferation by Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576 [TBL] [Abstract][Full Text] [Related]
10. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells. Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401 [TBL] [Abstract][Full Text] [Related]
11. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L; Zhang J; Fan Y; Li Y Med Sci Monit; 2019 Oct; 25():7864-7871. PubMed ID: 31631173 [TBL] [Abstract][Full Text] [Related]
12. Triticuside A, a dietary flavonoid, inhibits proliferation of human breast cancer cells via inducing apoptosis. Shan Y; Cheng Y; Zhang Y; Guan FQ; Sun H; Ren XC; Chen Y; Feng X; Yang JM Nutr Cancer; 2013; 65(6):891-9. PubMed ID: 23909734 [TBL] [Abstract][Full Text] [Related]
13. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
14. Total saponins of Bolbostemma paniculatum (maxim.) Franquet exert antitumor activity against MDA-MB-231 human breast cancer cells via inhibiting PI3K/Akt/mTOR pathway. Dou JW; Shang RG; Lei XQ; Li KL; Guo ZZ; Ye K; Yang XJ; Li YW; Zhou YY; Yao J; Huang Q BMC Complement Altern Med; 2019 Nov; 19(1):304. PubMed ID: 31703679 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of PI3K-Akt-mTOR signal pathway dismissed the stimulation of glucose on goose liver cell growth. Wei S; Han C; He F; Song Q; Kang B; Liu H; Li L; Xu H; Zeng X J Anim Physiol Anim Nutr (Berl); 2017 Oct; 101(5):e133-e143. PubMed ID: 27859698 [TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of caffeic acid n‑butyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathway. Zeng N; Hongbo T; Xu Y; Wu M; Wu Y Mol Med Rep; 2018 Apr; 17(4):5652-5657. PubMed ID: 29436638 [TBL] [Abstract][Full Text] [Related]
17. Silybin suppresses cell proliferation and induces apoptosis of multiple myeloma cells via the PI3K/Akt/mTOR signaling pathway. Feng N; Luo J; Guo X Mol Med Rep; 2016 Apr; 13(4):3243-8. PubMed ID: 26936429 [TBL] [Abstract][Full Text] [Related]
18. 20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway. Zhang H; Xu HL; Wang YC; Lu ZY; Yu XF; Sui DY Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614812 [TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway. Liu H; Liu C; Wang M; Sun D; Zhu P; Zhang P; Tan X; Shi G Sci Rep; 2021 Sep; 11(1):19268. PubMed ID: 34588580 [TBL] [Abstract][Full Text] [Related]
20. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]